Patents by Inventor Kevin O`Hayer

Kevin O`Hayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11896595
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: February 13, 2024
    Assignee: Incyte Corporation
    Inventors: Richard L. Schaub, Kevin O'Hayer
  • Publication number: 20220331325
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Application
    Filed: June 30, 2022
    Publication date: October 20, 2022
    Inventors: Richard L. Schaub, Kevin O`Hayer
  • Patent number: 11406640
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: August 9, 2022
    Assignee: Incyte Corporation
    Inventors: Richard L. Schaub, Kevin O'Hayer
  • Publication number: 20200281931
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 10, 2020
    Inventors: Richard L. Schaub, Kevin O`Hayer